Search

Anna Pagonakis

Examiner (ID: 6985)

Most Active Art Unit
1628
Art Unit(s)
1614, 4173, 1609, 1628, OPET
Total Applications
1238
Issued Applications
444
Pending Applications
73
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5035317 [patent_doc_number] => 20070099856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Combined treatment with docetaxel and an epidermal growth factor receptor kinase inhibitor using an intermittent dosing regimen' [patent_app_type] => utility [patent_app_number] => 11/434533 [patent_app_country] => US [patent_app_date] => 2006-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12559 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099856.pdf [firstpage_image] =>[orig_patent_app_number] => 11434533 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/434533
Combined treatment with docetaxel and an epidermal growth factor receptor kinase inhibitor using an intermittent dosing regimen May 14, 2006 Abandoned
Array ( [id] => 4698951 [patent_doc_number] => 20080221135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 11/382737 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2744 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221135.pdf [firstpage_image] =>[orig_patent_app_number] => 11382737 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/382737
COMBINATION THERAPY May 10, 2006 Abandoned
Array ( [id] => 4814059 [patent_doc_number] => 20080194690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Pharmaceutical Formulations Of Hdac Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/913191 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20784 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194690.pdf [firstpage_image] =>[orig_patent_app_number] => 11913191 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/913191
Pharmaceutical formulations of HDAC inhibitors May 10, 2006 Issued
Array ( [id] => 4613226 [patent_doc_number] => 07989445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Thienopyrimidone compound' [patent_app_type] => utility [patent_app_number] => 11/919301 [patent_app_country] => US [patent_app_date] => 2006-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26639 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989445.pdf [firstpage_image] =>[orig_patent_app_number] => 11919301 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/919301
Thienopyrimidone compound Apr 26, 2006 Issued
Array ( [id] => 5057731 [patent_doc_number] => 20070060653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Physiologic vaginal lubrication to optimize sperm survival and function' [patent_app_type] => utility [patent_app_number] => 11/407383 [patent_app_country] => US [patent_app_date] => 2006-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060653.pdf [firstpage_image] =>[orig_patent_app_number] => 11407383 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/407383
Physiologic vaginal lubrication to optimize sperm survival and function Apr 18, 2006 Abandoned
Array ( [id] => 5480761 [patent_doc_number] => 20090203718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'CANCER TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 12/296972 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14332 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12296972 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/296972
CANCER TREATMENT METHOD Apr 12, 2006 Abandoned
Array ( [id] => 5661118 [patent_doc_number] => 20060251714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Pharmaceutical formulations of amyloid inhibiting compounds' [patent_app_type] => utility [patent_app_number] => 11/402267 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 41827 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251714.pdf [firstpage_image] =>[orig_patent_app_number] => 11402267 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/402267
Pharmaceutical formulations of amyloid inhibiting compounds Apr 11, 2006 Abandoned
Array ( [id] => 5858019 [patent_doc_number] => 20060228405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Phospholipid-based pharmaceutical formulations and methods for producing and using same' [patent_app_type] => utility [patent_app_number] => 11/279088 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12843 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228405.pdf [firstpage_image] =>[orig_patent_app_number] => 11279088 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/279088
Phospholipid-based pharmaceutical formulations and methods for producing and using same Apr 6, 2006 Abandoned
Array ( [id] => 4960646 [patent_doc_number] => 20080275071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Radiotherapy Enhancer' [patent_app_type] => utility [patent_app_number] => 11/910123 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6982 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275071.pdf [firstpage_image] =>[orig_patent_app_number] => 11910123 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910123
Radiotherapy Enhancer Mar 30, 2006 Abandoned
Array ( [id] => 5051931 [patent_doc_number] => 20070032476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/390480 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9247 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032476.pdf [firstpage_image] =>[orig_patent_app_number] => 11390480 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/390480
Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof Mar 27, 2006 Issued
Array ( [id] => 8177272 [patent_doc_number] => 08178528 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Histamine H3 receptor agents, preparation and therapeutic uses' [patent_app_type] => utility [patent_app_number] => 11/909727 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178528.pdf [firstpage_image] =>[orig_patent_app_number] => 11909727 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/909727
Histamine H3 receptor agents, preparation and therapeutic uses Mar 27, 2006 Issued
Array ( [id] => 4887717 [patent_doc_number] => 20080262049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Therapeutic Agent for Hematopoietic Tumor' [patent_app_type] => utility [patent_app_number] => 11/909324 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26055 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262049.pdf [firstpage_image] =>[orig_patent_app_number] => 11909324 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/909324
Therapeutic Agent for Hematopoietic Tumor Mar 21, 2006 Abandoned
Array ( [id] => 4698936 [patent_doc_number] => 20080221120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Modulation of Aquaporin in Modulation of Angiogenesis and Cell Migration' [patent_app_type] => utility [patent_app_number] => 11/908399 [patent_app_country] => US [patent_app_date] => 2006-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18350 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221120.pdf [firstpage_image] =>[orig_patent_app_number] => 11908399 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908399
Modulation of Aquaporin in Modulation of Angiogenesis and Cell Migration Mar 20, 2006 Abandoned
Array ( [id] => 5705792 [patent_doc_number] => 20060194840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Method for treating snoring and sleep apnea with leukotriene antagonists' [patent_app_type] => utility [patent_app_number] => 11/385583 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10210 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194840.pdf [firstpage_image] =>[orig_patent_app_number] => 11385583 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/385583
Method for treating snoring and sleep apnea with leukotriene antagonists Mar 19, 2006 Abandoned
Array ( [id] => 5890206 [patent_doc_number] => 20060276534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Methods of decreasing calcification' [patent_app_type] => utility [patent_app_number] => 11/378879 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11459 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276534.pdf [firstpage_image] =>[orig_patent_app_number] => 11378879 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/378879
Methods of decreasing calcification Mar 16, 2006 Abandoned
Array ( [id] => 5700752 [patent_doc_number] => 20060217437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'TGF-beta modulators and methods for using the same' [patent_app_type] => utility [patent_app_number] => 11/384113 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7878 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217437.pdf [firstpage_image] =>[orig_patent_app_number] => 11384113 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/384113
TGF-beta modulators and methods for using the same Mar 16, 2006 Abandoned
Array ( [id] => 5297125 [patent_doc_number] => 20090012051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'EXTERNAL PREPARATION' [patent_app_type] => utility [patent_app_number] => 11/908232 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9463 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012051.pdf [firstpage_image] =>[orig_patent_app_number] => 11908232 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908232
EXTERNAL PREPARATION Mar 14, 2006 Abandoned
Array ( [id] => 4960577 [patent_doc_number] => 20080275002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Method for Treatment of Hepatic Cancer' [patent_app_type] => utility [patent_app_number] => 11/817986 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3783 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275002.pdf [firstpage_image] =>[orig_patent_app_number] => 11817986 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817986
Method for Treatment of Hepatic Cancer Mar 6, 2006 Abandoned
Array ( [id] => 5258699 [patent_doc_number] => 20070212331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Methods and compositions for selectively killing cells' [patent_app_type] => utility [patent_app_number] => 11/369786 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8213 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212331.pdf [firstpage_image] =>[orig_patent_app_number] => 11369786 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/369786
Methods and compositions for selectively killing cells Mar 6, 2006 Abandoned
Array ( [id] => 5700670 [patent_doc_number] => 20060217355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/370218 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8667 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217355.pdf [firstpage_image] =>[orig_patent_app_number] => 11370218 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/370218
Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer Mar 5, 2006 Abandoned
Menu